A Closer Look at the Dermatological Profile of GLP-1 Agonists
In CVOTs, liraglutide, semaglutide and dulaglutide demonstrated appreciable cardiovascular and renal protective effects, among which liraglutide had an appreciable effect on mitigating the risk of cardiovascular death [4], while semaglutide and dulaglutide conferred a risk reduction on non-fatal stroke [22, 23]
Due to these potential benefits, various GLP-1 medications are FDA-approved to treat obesity, type 2 diabetes, or both
Each bottle comes with 1 month of supply
It stimulates the production and release of insulin and inhibits the production of glucagon, helping to lower blood sugar levels in people with type 2 diabetes
In the ovaries, GLP-1: Reduces androgen production (less excess testosterone) Increases sex hormone-binding globulin Improves ovulation rates For people with PCOS, this can mean more regular cycles and better chances of ovulating